These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cloning and characterization of a polymorphic class I MHC gene in the AKR lymphoma K36.16. Sim BC; Hui KM J Immunogenet; 1989; 16(4-5):335-41. PubMed ID: 2639906 [TBL] [Abstract][Full Text] [Related]
3. Promotion of tumor growth by transfecting antisense DNA to suppress endogenous H-2Kk MHC gene expression in AKR mouse thymoma. Hui KM; Sim BC; Foo TT; Oei AA Cell Immunol; 1991 Aug; 136(1):80-94. PubMed ID: 2060026 [TBL] [Abstract][Full Text] [Related]
4. Aberrant H-2-like allospecificities on K36.16 thymoma. Studies by radiobinding and immunoprecipitation with anti-H-2 monoclonal antibodies. Festenstein H; Hui KM J Immunogenet; 1986; 13(2-3):113-6. PubMed ID: 3819447 [TBL] [Abstract][Full Text] [Related]
5. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene. Hui KM; Sim T; Foo TT; Oei AA J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720 [TBL] [Abstract][Full Text] [Related]
6. Dominant allele-specific regulation of expression of H-2Kk gene products revealed by somatic cell hybridization. Bishop CE; Lewis CM; Festenstein H Somatic Cell Genet; 1982 Sep; 8(5):623-34. PubMed ID: 7135165 [TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias. Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124 [TBL] [Abstract][Full Text] [Related]
8. Apparent alteration in MHC antigens in K36.16, an AKR thymoma, does not result in genetic rearrangement. Lewis CM; Bishop CE Immunology; 1983 Nov; 50(3):433-40. PubMed ID: 6629416 [TBL] [Abstract][Full Text] [Related]
9. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR. Schmidt W; Festenstein H J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751 [TBL] [Abstract][Full Text] [Related]
10. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation. Hui K; Grosveld F; Festenstein H Nature; 1984 Oct 25-31; 311(5988):750-2. PubMed ID: 6333639 [TBL] [Abstract][Full Text] [Related]
11. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia. Schmidt W; Festenstein H Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849 [TBL] [Abstract][Full Text] [Related]
12. Cell surface antigen phenotypes of MCF-induced thymic lymphomas in AKR mice. Yetter RA; Morse HC J Immunol; 1984 May; 132(5):2644-8. PubMed ID: 6609203 [TBL] [Abstract][Full Text] [Related]
13. Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb. Chinsky J; Lilly F; Childs G Proc Natl Acad Sci U S A; 1985 Jan; 82(2):565-9. PubMed ID: 3855567 [TBL] [Abstract][Full Text] [Related]
14. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410 [TBL] [Abstract][Full Text] [Related]
15. H-2-specific antibodies induced by injection of syngeneic leukemia cells. Schmidt W Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375 [TBL] [Abstract][Full Text] [Related]
16. [Detection of DNA sequences sensitive to glucocorticoids in the thymus of AKR mice and their inactivation in thymoma]. Novikova VM; Dashkevich VS; Vishnivetskiĭ SN; Kaledin VI; Mertvetsov NP Biull Eksp Biol Med; 1986 Nov; 102(11):563-6. PubMed ID: 3779082 [TBL] [Abstract][Full Text] [Related]
17. Acquisition of immunogenicity by AKR leukemic cells following DNA-mediated gene transfer is associated with the reduction of constitutive reactive superoxide radicals. Chia KY; Lim SP; Oei AA; Sabapathy TK; Hui KM Int J Cancer; 1994 Apr; 57(2):216-23. PubMed ID: 8157360 [TBL] [Abstract][Full Text] [Related]
18. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control. Green WR J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409 [TBL] [Abstract][Full Text] [Related]
19. T cell receptor beta-chain genes in BW5147 and other AKR tumors. Deletion order of murine V beta gene segments and possible 5' regulatory regions. Lee NE; Davis MM J Immunol; 1988 Mar; 140(5):1665-75. PubMed ID: 3346546 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of MHC products on AKR lymphoma cells. Oudshoorn-Snoek M; Demant P Transplant Proc; 1983 Dec; 15(4):2104-6. PubMed ID: 6424291 [No Abstract] [Full Text] [Related] [Next] [New Search]